SPHINGOTEC GROUP


COMBINING INNOVATIVE BIOMARKERS WITH OUTSTANDING TECHNOLOGY

logo_shpingotec

LATEST NEWS


Sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology.

Learn more

Endothelial disruption: Rapid translation from bench to bedside.

Learn more

Sphingotec raises €20 million from HBM and Wellington Partners.

Learn more

Sphingotec is adding an advanced POC testing platform to portfolio

Learn more